Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation-Reference-Cited by-同舟云学术

Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation

Published:2015-03-04 Issue:8 Volume:104 Page:656-665
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Gloekler Steffen,Shakir Samera,Doblies Janosch,Khattab Ahmed A.,Praz Fabien,Guerios Ênio,Koermendy Dezsoe,Stortecky Stefan,Pilgrim Thomas,Buellesfeld Lutz,Wenaweser Peter,Windecker Stephan,Moschovitis Aris,Jaguszewski Milosz,Landmesser Ulf,Nietlispach Fabian,Meier Bernhard

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00392-015-0828-1.pdf

Reference38 articles.

1. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P (2009) PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374:534–542

2. Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin JL, Holmes D (2013) PROTECT AF Investigators. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) Trial. Circulation 127:720–729

3. Landmesser U, Holmes DR (2012) Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation. Eur Heart J 33:698–704

4. Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY (2014) Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy. J Am Coll Cardiol 64:1–12

5. Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, Huber K, Whisenant B, Kar S, Swarup V, Gordon N, Holmes D (2014) PROTECT AF Steering Committee and Investigators. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA 312:1988–1998

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness;Revista Española de Cardiología (English Edition);2024-02

2. Efectividad y seguridad de una estrategia de antiagregación plaquetaria simple tras cierre percutáneo de orejuela izquierda en pacientes con FA;Revista Española de Cardiología;2024-02

3. Risk factors, clinical implications, and management of peridevice leak following left atrial appendage closure: A systematic review;Journal of Interventional Cardiac Electrophysiology;2024-01-06

4. Occlusion Devices for Cardiovascular Disease;Application of Biomaterials in the Treatment of Cardiovascular Diseases;2024

5. The CT derived angle between the transseptal puncture site and the left atrial appendage as a predictor for complex interventional occlusion procedures;Echocardiography;2023-10-03